AIMD
Ainos, Inc.
There isn't enough reported data to score AIMD yet.
AIMD Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
AIMD's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
AIMD PE Valuation
AIMD has no meaningful PE right now: it lost money over the past year.
AIMD Forward outlook
There aren't enough analyst estimates for AIMD to show an outlook.
AIMD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.29 | +$1.25 |
| Q1 2026 | -$3.66 | +$2.34 |
| Q4 2025 | -$4.30 | +$3.50 |
| Q2 2021 | -$11.25 | +$7.50 |
| Q1 2021 | -$15.00 | $0.00 |
| Q4 2020 | -$15.00 | $0.00 |
| Q3 2020 | -$18.75 | -$3.75 |
AIMD is still losing money, but far less than before: $3.29 per share over the past year, against $18.75 at its worst in mid-2020.
AIMD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $152 | -97% |
| Q1 2026 | $161 | -100% |
| Q1 2025 | $106.2K | +412% |
| Q1 2024 | $20.7K | -58% |
| Q4 2023 | $19.9K | -98% |
| Q3 2023 | $24.5K | -99% |
| Q2 2023 | $28.6K | -96% |
| Q1 2023 | $49.2K | -44% |
AIMD's revenue has slid since its 2022 peak: $152 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2894136% | -2813808 points |
| Q1 2026 | -1418414% | -1415436 points |
| Q4 2025 | -38648% | N/A |
| Q3 2025 | -128481% | N/A |
| Q2 2025 | -80328% | N/A |
| Q1 2025 | -2978% | +12074 points |
| Q1 2024 | -15052% | -9940 points |
| Q4 2023 | -28643% | -28438 points |
AIMD's operating margin was −2894136% last quarter, down 2813808 points from the same quarter a year ago, near the bottom of its range since 2019.
AIMD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.5M | -$111.4K |
| Q1 2026 | -$992K | +$266.3K |
| Q4 2025 | -$853.5K | +$11.7K |
| Q3 2025 | -$1.2M | +$290.5K |
| Q2 2025 | -$1.3M | +$637.3K |
| Q1 2025 | -$1.3M | +$241K |
| Q4 2024 | -$865.1K | +$492.9K |
| Q2 2024 | -$2M | -$829K |
AIMD has burned cash in almost every quarter: −$4M over the past year, against −$5M the year before.
AIMD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +22% | +1.3M shares |
| 1 year | +132% | +4.2M shares |
| 3 years | +819% | +6.6M shares |
| 5 years | +6709% | +7.2M shares |
AIMD has 7M diluted shares, up 132% from a year ago.
AIMD Net Leverage
AIMD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AIMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.6 | Neutral |
| Stochastic | 19.5 | Oversold |
AIMD's weekly RSI is 43 (neutral) and its Stochastic is 20 (oversold).
AIMD PE vs Healthcare Sector
AIMD has no meaningful PE right now: it lost money over the past year.
AIMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.01 | 5% above |
| 20 week MA | $1.32 | 20% below |
| 50 week MA | $1.60 | 34% below |
| 100 week MA | $2.30 | 54% below |
| 200 week MA | $6.77 | 84% below |
AIMD has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 84% below its 200-week average.
AIMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $57.4 | $255.0 | +344% |
| 2022 | $255.0 | $15.7 | -94% |
| 2023 | $15.7 | $10.3 | -35% |
| 2024 | $10.3 | $2.27 | -78% |
| 2025 | $2.27 | $1.95 | -14% |
| 2026 YTD | $1.95 | $1.06 | -46% |
AIMD has finished four years in a row lower, and it's down 46% so far in 2026.